The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Sunday, May 7, 2017

healio : declared in FDA approves medication to treat Lou Gehrig’s Disease

FDA NewsThe FDA approved Radicava for the treatment of ALS, the first new treatment approved "in many years," according to an FDA director. According to the press release, the most common adverse effects reported in the trial were bruising and gait disturbance. This treatment repeats with dosing 10 out of 14 days and another 14-day drug-free period, according to the FDA. A clinical trial in Japan including 137 participants treated with edaravone showed clinically less decline on assessment of daily functioning compared to those receiving placebo. Additionally, some effects require immediate attention, such as hives, swelling, shortness of breath and allergic reaction to sodium bisulfite.


New Help for Sufferers of Lou Gehrig's Disease

The Food and addiction Administration announced Friday it approved a new drug to help treat amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig's disease. The agency said it approved the drug Radicava, or edaravone, the first new drug approved to treat ALS in 22 years. The only other drug used specifically to treat ALS is riluole, which was approved in 1995. The Centers for Disease Control and Prevention estimates that about 12,000 to 15,000 Americans suffer from the disease. Tests on more than 100 patients showed the drug slowed some of the effects of the disease, which eventually paralyzes patients.

Is Lou Gehrig's Disease Finally Curable? FDA Approves New ALS Treatment
AdvertisementU.S. federal health regulators have approved a new drug for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. "We hope today's announcement signals the beginning of a new chapter in the fight against this terrible disease," the ALS association said. Research funded by the proceeds of the ice bucket challenge, for instance, has identified a gene responsible for ALS. The drug called Radicava or edaravone, is the second drug to be greenlighted by the FDA for the condition after more than 20 years. After six months, the conditions of those who were given the drug declined less than those who were given placebo.


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases

No comments:

Post a Comment